Skip to main content
. 2014 Apr 22;9(4):e95310. doi: 10.1371/journal.pone.0095310

Table 2. Bone scan results.

Bone scan Docetaxel Monotherapy Docetaxel/Sunitinib
No change or improvement 6 (46%) 8 (57%)
New lesions or increased tracer uptake 4 (30%) 1 (7%)
No bone lesions or N.A 3 (23%) 5 (36%)